Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
Critical Care2011Vol. 15(2), pp. R79–R79
Citations Over TimeTop 10% of 2011 papers
Mi Kyong Joung, Jeong-A Lee, Soo‐youn Moon, Hae Suk Cheong, Eun‐Jeong Joo, Young-Eun Ha, Kyung Mok Sohn, Seung Min Chung, Gee Young Suh, Doo Ryeon Chung, Jae‐Hoon Song, Kyong Ran Peck
Abstract
Patients in the de-escalation group showed a significantly lower mortality rate compared to patients in the non-de-escalation group. De-escalation therapy can be safely provided to patients with ICU-acquired pneumonia if they are clinically stable by day 5, even in those whose respiratory specimen cultures yield no specific pathogens.
Related Papers
- → The comparison of apache II and apache IV score to predict mortality in intensive care unit in a tertiary care hospital(2019)13 cited
- → Incidence and Outcome of Ventilator Associated Pneumonia in ICU of a Tertiary Care Hospital in Nepal(2017)9 cited
- → Decreasing ventilator-associated pneumonia in the intensive care unit: A sustainable comprehensive quality improvement program(2012)17 cited
- → Escalation/De-escalation of Initial Empiric Ventilator-Associated Pneumonia Therapy: Interim Results from the Assessment of Local Antimicrobial Resistance Measures Study(2004)3 cited